If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompass Group Regulatory News (CPG)

Share Price Information for Compass Group (CPG)

Share Price is delayed by 15 minutes
Get Live Data
33.16    1.13 (3.53%)
Bid:
33.25
Ask:
33.27
Spread: 0.02 (0.06%)
Market Cap: $56.38b
CPG Live PriceLast checked at - London Stock Exchange

Intraday Compass Group Share Chart

Q3 Trading Update

22 Jul 2025 07:00

RNS Number : 9481R
Compass Group PLC
22 July 2025
 

 

Legal Entity Identifier (LEI) No. 2138008M6MH9OZ6U2T68

 
 

 

 

 

 

Upgrading FY25 profit guidance due to strong organic growth and better than expected M&A performance

Agreed to acquire Vermaat for €1.5bn

22 July 2025 - Compass Group PLC, a global leader in food services, today announces trading results for the third quarter ended 30 June 2025.

 

Group and regional performance

 

Compass delivered another strong performance with organic revenue growth of 8.6% in the third quarter and 8.5% for the year to date. Both regions performed well, with North America delivering strong growth across all sectors. Net new business growth continued in the middle of our 4 - 5% target range, supported by strong client retention of over 96%.

 

Organic revenue growth1

Q3 2025

Q3 YTD 2025

North America

9.6%

9.0%

International

6.6%

7.6%

Group

8.6%

8.5%

1 Year on year change

 

Volume growth in both regions remained positive, with North America particularly strong as it benefited from favourable hospitality events. Growth in International was slightly lower compared to Q2, due to mobilisation timings. Pricing was in line with our expectations.

 

Acquisition and disposals

 

The Group's net expenditure on M&A was $1.1bn for the year to date, largely unchanged from its position at the half year. The integration of recent acquisitions is progressing ahead of expectations, and they are performing well.

 

Today we have announced an agreement to acquire Vermaat Groep B.V., a leading premium food services business in Europe, for an Enterprise Value of approximately €1.5bn. Further details are provided in an accompanying stock exchange announcement.  This transaction is subject to regulatory approval and consultation with the Vermaat Works Council.

 

Currency

 

If current spot rates were to continue for the remainder of the year, foreign exchange translation would negatively impact 2024 revenue by $57m1 and operating profit by $13m1.

1 Based on spot rates as of 17 July 2025

 

Summary and guidance

 

We are pleased with our third quarter performance with continued strong organic revenue growth and M&A performing better than expected. 

 

As a result, we are upgrading our 2025 guidance. We now expect constant currency underlying operating profit growth to be towards 11%, driven by organic revenue growth above 8% and ongoing margin progression.

 

Sectorisation deep dive

The Group will share a virtual deep dive in September 2025, relating to how it sectorises the market, operating in distinct sectors through a unique portfolio of brands, which is a key competitive advantage.

Conference call

There will be a live Q&A session for analysts and investors at 9.00am BST. Please connect to the call at least 10 minutes prior to the start time by dialling:

UK Toll Number: 

+44 (0) 33 0551 0200

UK Toll-Free Number: 

0808 109 0700 

New York Number: 

+1 786 697 3501

US Toll-Free Number: 

866 580 3963

Please reference: COMPASS  

Financial calendar

Payment date for 2024 interim dividend

Sectorisation deep dive

31 July 2025

September 2025

Full year results

 25 November 2025

 

 

Enquiries

 

Investors

Agatha Donnelly, Simon Bielecki

 

+44 1932 573 000

Press

Amy Shields

Tim Danaher, Brunswick

 

+44 1932 573 000

+44 207 404 5959

Website

www.compass-group.com

 

Forward-looking statements

Certain information included in this Announcement is forward-looking and involves risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed or implied by forward-looking statements. Forward-looking statements cover all matters which are not historical facts and include, without limitation, the direct and indirect future impacts and implications of: public health crises such as the COVID-19 pandemic on the economy, nationally and internationally, and on the Group, its operations and prospects; risks associated with changes in environmental scenarios and related regulations including (without limitation) the evolution and development of the global transition to a low carbon economy (including increasing societal and investor expectations); disruptions and inefficiencies in supply chains (such as resulting from the wars in Ukraine and the Middle East); future domestic and global political, economic and business conditions (such as inflation or the UK's exit from the EU); projections relating to results of operations and financial conditions and the Company's plans and objectives for future operations, including, without limitation, discussions of expected future revenues, financing plans and expected expenditures and divestments; risks associated with changes in economic conditions, levels of economic growth and the strength of the food and support services markets in the jurisdictions in which the Group operates; fluctuations in food and other product costs and labour costs; prices and changes in exchange and interest rates; and the impacts of technological advancements. Forward-looking statements can be identified by the use of forward-looking terminology, including terms such as 'believes', 'estimates', 'anticipates', 'expects', 'forecasts', 'intends', 'plans', 'projects', 'goal', 'target', 'aim', 'may', 'will', 'would', 'could' or 'should' or, in each case, their negative or other variations or comparable terminology.

 

Forward-looking statements in this Announcement are not guarantees of future performance. All forward-looking statements in this Announcement are based upon information known to the Company on the date of this Announcement. Accordingly, no assurance can be given that any particular expectation will be met and readers are cautioned not to place undue reliance on forward-looking statements when making their investment decisions. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation or warranty that such trends or activities will continue in the future. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Nothing in this Announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEDDVILFIE
Date   Source Headline
18th Dec 201710:05 amRNSAnnual Financial Report
30th Nov 20175:30 pmRNSTotal Voting Rights
28th Nov 20175:55 pmRNSDirector/PDMR Shareholding
24th Nov 20174:26 pmRNSDirector/PDMR Shareholding
24th Nov 20179:00 amRNSDirector/PDMR Shareholding
21st Nov 20178:32 amRNSFull year results - year ended 30 Sept 17
21st Nov 20177:00 amRNSFull year results for year ended 30 Sept 2017
31st Oct 20176:27 pmRNSTotal Voting Rights
9th Oct 20172:48 pmRNSDirector/PDMR Shareholding
9th Oct 20171:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20179:00 amRNSTotal Voting Rights
2nd Oct 20177:00 amRNSBlock listing Interim Review
21st Sep 20177:00 amRNSCompass Group PLC CEO Succession
1st Sep 20178:00 amRNSTotal Voting Rights
1st Aug 20178:00 amRNSTotal Voting Rights
26th Jul 20177:00 amRNSThird Quarter Update
19th Jul 20177:00 amRNSDirector/PDMR Shareholding
17th Jul 201710:39 amRNSPayment of Special Dividend of c.£1 billion
3rd Jul 20177:00 amRNSTotal Voting Rights
27th Jun 20177:00 amRNSShare Capital Consolidation and Admission
26th Jun 20176:05 pmRNSCorrection of ISIN and Common codes EMTN Programme
26th Jun 20176:00 pmRNSCorrection of ISIN and Common codes EMTN Programme
21st Jun 20175:18 pmRNSEuro Medium Term Note Programme - Final Terms
20th Jun 201711:24 amRNSDirector/PDMR Shareholding
14th Jun 201711:49 amRNSTransaction in Own Shares
8th Jun 20177:00 amRNSUpdate relating to Shareholder Return
8th Jun 20177:00 amRNSResult of General Meeting
1st Jun 20179:53 amRNSUpdate of Euro Medium Term Note Programme
1st Jun 20177:00 amRNSTotal Voting Rights
15th May 201712:03 pmRNSShareholder Return and Notice of General Meeting
11th May 20179:51 amRNSDirector/PDMR Shareholding
10th May 20177:00 amRNSHalf year results announcement
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20175:04 pmRNSTransaction in Own Shares
20th Apr 20174:53 pmRNSTransaction in Own Shares
19th Apr 20174:59 pmRNSTransaction in Own Shares
7th Apr 20175:07 pmRNSTransaction in Own Shares
6th Apr 20175:00 pmRNSTransaction in Own Shares
5th Apr 20175:00 pmRNSTransaction in Own Shares
4th Apr 20175:15 pmRNSTransaction in Own Shares
3rd Apr 20175:00 pmRNSTransaction in Own Shares
3rd Apr 20179:00 amRNSTotal Voting Rights
31st Mar 20175:43 pmRNSTransaction in Own Shares
31st Mar 201710:00 amRNSBlock listing Interim Review
30th Mar 20174:51 pmRNSTransaction in Own Shares
29th Mar 20175:06 pmRNSTransaction in Own Shares
28th Mar 20175:56 pmRNSTransaction in Own Shares
27th Mar 20174:53 pmRNSTransaction in Own Shares
24th Mar 20175:11 pmRNSTransaction in Own Shares
23rd Mar 20174:53 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.